Destiny Pharma plc – LSE:DEST.L
Destiny Pharma stock price today
Destiny Pharma stock price monthly change
Destiny Pharma stock price quarterly change
Destiny Pharma stock price yearly change
Destiny Pharma key metrics
Market Cap | 2.87M |
Enterprise value | N/A |
P/E | -3.05 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 1.25 |
PEG ratio | -0.11 |
EPS | -0.15 |
Revenue | N/A |
EBITDA | -14.64M |
Income | -12.16M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDestiny Pharma stock price history
Destiny Pharma stock forecast
Destiny Pharma financial statements
| Jun 2022 | 0 | -3.18M | |
|---|---|---|---|
| Dec 2022 | 154.49K | -3.31M | -2145.82% |
| Jun 2023 | 831.55K | -2.65M | -319.84% |
| Dec 2023 | 0 | -2.99M |
| 2025 | 1.39M | -8M | -572.59% |
|---|---|---|---|
| 2026 | 1.81M | -14.5M | -800.64% |
| 2027 | 3.77M | -9.06M | -240.51% |
| 2028 | 3.04M | -9.06M | -297.97% |
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 3993053 | 1.38M | 34.64% |
|---|---|---|---|
| Jun 2023 | 13046035 | 1.12M | 8.64% |
| Sep 2023 | 4569199 | 1.92M | 42.23% |
| Dec 2023 | 9957484 | 768.31K | 7.72% |
| Dec 2022 | -3.51M | 47.12K | 0 |
|---|---|---|---|
| Mar 2023 | -251.40K | -568.84K | 725.08K |
| Jun 2023 | -1.83M | 30.59K | 6.74M |
| Sep 2023 | -376.42K | -104.09K | 464.67K |
Destiny Pharma alternative data
| Aug 2023 | 24 |
|---|---|
| Sep 2023 | 24 |
| Oct 2023 | 24 |
| Nov 2023 | 24 |
| Dec 2023 | 24 |
| Jan 2024 | 24 |
| Feb 2024 | 24 |
| Mar 2024 | 24 |
| Apr 2024 | 24 |
| May 2024 | 24 |
| Jun 2024 | 24 |
| Jul 2024 | 15 |
Destiny Pharma other data
| Insider | Compensation |
|---|---|
Mr. Neil Robert Clark (1963) Chief Executive Officer & Director | $325,000 |
Dr. William Guy Love (1963) Founder, Chief Scientific Officer & Director | $275,000 |
Mr. Shaun Claydon (1969) Chief Financial Officer, Company Sec. & Director | $240,000 |
-
What's the price of Destiny Pharma stock today?
One share of Destiny Pharma stock can currently be purchased for approximately $105.
-
When is Destiny Pharma's next earnings date?
Unfortunately, Destiny Pharma's (DEST.L) next earnings date is currently unknown.
-
Does Destiny Pharma pay dividends?
No, Destiny Pharma does not pay dividends.
-
How much money does Destiny Pharma make?
Destiny Pharma has a market capitalization of 2.87M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 438.22% to 831.55K US dollars.
-
What is Destiny Pharma's stock symbol?
Destiny Pharma plc is traded on the LSE under the ticker symbol "DEST.L".
-
What is Destiny Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Destiny Pharma?
Shares of Destiny Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Destiny Pharma's key executives?
Destiny Pharma's management team includes the following people:
- Mr. Neil Robert Clark Chief Executive Officer & Director(age: 62, pay: $325,000)
- Dr. William Guy Love Founder, Chief Scientific Officer & Director(age: 62, pay: $275,000)
- Mr. Shaun Claydon Chief Financial Officer, Company Sec. & Director(age: 56, pay: $240,000)
-
Is Destiny Pharma founder-led company?
Yes, Destiny Pharma is a company led by its founder Dr. William Guy Love.
-
How many employees does Destiny Pharma have?
As Jul 2024, Destiny Pharma employs 15 workers, which is 38% less then previous month and 38% less then previous quarter.
-
When Destiny Pharma went public?
Destiny Pharma plc is publicly traded company for more then 8 years since IPO on 4 Sep 2017.
-
What is Destiny Pharma's official website?
The official website for Destiny Pharma is destinypharma.com.
-
How can i contact Destiny Pharma?
Destiny Pharma can be reached via phone at +44 1273 704440.
Destiny Pharma company profile:
Destiny Pharma plc
destinypharma.comLSE
15
Biotechnology
Healthcare
Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Biofilm that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, oral mucosa, and ocular infection diseases. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; the University of Southampton; Aston University; the University of Sheffield; and Cardiff University and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.
Brighton, BN1 9SB
:
ISIN: GB00BDHSP575
CUSIP: G27357105
